tiprankstipranks
pc:thior

Thioredoxin Systems AB (TXN Systems)

Nanna Svartz väg 2 Solna, Stockholm 171 65, SE
https://www.txnsystems.com/
Thioredoxin Systems AB (TXN Systems) is a pharmaceutical company focused on developing EbsArgent™, a first-in-class bactericidal antibiotic designed to treat urinary tract infections caused by multidrug-resistant bacteria. The company's innovative approach targets a critical need in combating antibiotic resistance, aiming to provide effective solutions for challenging infections.

Leadership & Board

Current Number of Employees7
Current LinkedIn Followers280

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$25M
Total Amount Raised$25M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$25M
Latest Funding Amount$25M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Employee Trend

Thioredoxin Systems AB (TXN Systems) had 7 employees as of April 6, 2026. The number of employees decreased by 1 (12.50%) week-over-week.
7Latest Employee Count
1(-12.50%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Thioredoxin Systems AB (TXN Systems) had 280 followers as of April 6, 2026. The number of followers increased by 0 (0.00%) week-over-week.
280Latest Followers Count
0(0.00%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Aug 14, 2025
Series A
$25.00M

Investors

Investor Name
Funding Round

Related News and Analysis